South Dakota Investment Council Gsk PLC Transaction History

South Dakota Investment Council

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$40.46 - $43.52 $407,553 - $438,376	-10,073 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$36.18 - $40.15 $7,706 - $8,551	-213 Reduced 2.07%	10,073 $394,000
Q4 2017 Feb 09, 2018	SELL	$35.34 - $41.9 $85,522 - $101,398	-2,420 Reduced 19.05%	10,286 $365,000
Q3 2017 Nov 09, 2017	BUY	$39.44 - $41.55 $501,124 - $527,934	12,706	12,706 $516,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.5B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

Stay updated on South Dakota Investment Council with notifications on news.